| O6-Cyclohexylmethoxy-2-(4'-sulphamoylanilino) purine | IC50 | 80.0 [1] |
| Seliciclib | IC50 | 500.0 [1] |
| 4-Nitro-2-{[4-(methylsulfanyl)benzylidene]amino}phenol | IC50 | 69800.0 [1] |
| Olomoucine | IC50 | 7000.0 [1] |
| Staurosporine | IC50 | 0.1 [1], 0.36 [2], 1.4 [3], 2.6 [4], 3.8 [5] |
| Alvocidib | IC50 | 40.0 [1], 170.0 [2] |
| Alvocidib | Ki | 190.0 [1] |
| Purvalanol A | IC50 | 4.0 [1], 35.0 [2], 70.0 [3] |
| Sns-032 | IC50 | 38.0 [1], 46.0 [2], 48.0 [3] |
| Sns-032 | Ki | 38.0 [1] |
| 6-O-Cyclohexylmethyl guanine | IC50 | 17000.0 [1] |
| 6-O-Cyclohexylmethyl guanine | Ki | 1200.0 [1], 12000.0 [2] |
| Cdk2 Inhibitor II | IC50 | 60.0 [1] |
| Oxindole-Based Inhibitor 20 | IC50 | 30.0 [1], 43.0 [2] |
| 2-(2-Chloro-N-[6-[4-[(2S)-3-(dimethylamino)-2-hydroxypropoxy]anilino]pyrimidin-4-yl]-5-methylanilino)acetonitrile | IC50 | 140.0 [1], 640.0 [2], 2600.0 [3], 7300.0 [4] |
| Dinaciclib | IC50 | 1.0 [1] |
| (3Z)-3-(1H-Imidazol-5-ylmethylene)-5-methoxy-1H-indol-2(3H)-one | IC50 | 22.0 [1], 35.0 [2], 110.0 [3] |
| 6-Cyclohexylmethyloxy-5-nitroso-pyrimidine-2,4-diamine | IC50 | 2200.0 [1] |
| 6-Cyclohexylmethyloxy-5-nitroso-pyrimidine-2,4-diamine | Ki | 1300.0 [1] |
| 4-(1-Isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine | IC50 | 6.0 [1] |
| Milciclib | IC50 | 45.0 [1], 363.0 [2] |
| 4-[(7-Hydroxy-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-yl)methylideneamino]-N-pyridin-2-ylbenzenesulfonamide | IC50 | 9.7 [1], 10.0 [2] |
| Oxindole-Based Inhibitor 29 | IC50 | 1.5 [1] |
| Oxindole-Based Inhibitor 22 | IC50 | 2.3 [1] |
| 4-[1-(2-Hydroxy-1H-indol-3-yl)ethylideneamino]benzenesulfonamide | IC50 | 360.0 [1] |
| 4-[[5-(Dimethylamino)-2-hydroxy-1H-indol-3-yl]methylideneamino]benzenesulfonamide | IC50 | 310.0 [1] |
| 4-[(7-Hydroxy-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-yl)methylideneamino]benzenesulfonamide | IC50 | 2.8 [1] |
| Oxindole-Based Inhibitor 60 | IC50 | 8.9 [1] |
| Oxindole-Based Inhibitor 66 | IC50 | 75.0 [1] |
| Oxindole-Based Inhibitor 43 | IC50 | 46.0 [1] |
| TrkA Inhibitor | IC50 | 690.0 [1] |
| Oxindole-Based Inhibitor 27 | IC50 | 2.5 [1] |
| Oxindole-Based Inhibitor 31 | IC50 | 3.4 [1] |
| Oxindole-Based Inhibitor 49 | IC50 | 16.0 [1] |
| Oxindole-Based Inhibitor 50 | IC50 | 43.0 [1] |
| Oxindole-Based Inhibitor 56 | IC50 | 4.5 [1] |
| [4-(2-Amino-4-methyl-thiazol-5-YL)-pyrimidin-2-YL]-(3-nitro-phenyl)-amine | Ki | 2.0 [1] |
| 1-(Dimethylamino)-3-[4-[[4-(2-methylimidazo[1,2-a]pyridin-3-yl)pyrimidin-2-yl]amino]phenoxy]propan-2-ol | IC50 | 1.0 [1], 10.0 [2], 32.0 [3] |
| (2S)-1-N-(5-Isoquinolin-6-yl-1,3,4-thiadiazol-2-yl)-3-[4-(trifluoromethyl)phenyl]propane-1,2-diamine | IC50 | 50.0 [1], 53.0 [2] |
| Oxindole-Based Inhibitor 57 | IC50 | 17.0 [1] |
| 4-[(2-Hydroxy-7-methyl-1H-indol-3-yl)methylideneamino]benzenesulfonamide | IC50 | 1000.0 [1], 10000.0 [2] |
| Oxindole-Based Inhibitor 44 | IC50 | 10.0 [1] |
| Oxindole-Based Inhibitor 61 | IC50 | 2.1 [1] |
| 4-[[2-Hydroxy-4-(hydroxymethyl)-1H-indol-3-yl]methylideneamino]benzenesulfonamide | IC50 | 54.0 [1] |
| 4-[1-(5-Chloro-2-hydroxy-1H-indol-3-yl)ethylideneamino]benzenesulfonamide | IC50 | 22.0 [1] |
| 4-[[5-(Methoxycarbonyl)-2-oxoindoline-3-ylidenemethyl]amino]benzenesulfonamide | IC50 | 2.1 [1] |
| 4-[[2-Hydroxy-6-(hydroxymethyl)-1H-indol-3-yl]methylideneamino]benzenesulfonamide | IC50 | 61.0 [1] |
| Oxindole-Based Inhibitor 40 | IC50 | 1000.0 [1] |
| Oxindole-Based Inhibitor 17 | IC50 | 120.0 [1] |
| Oxindole-Based Inhibitor 25 | IC50 | 4.6 [1] |
| Oxindole-Based Inhibitor 26 | IC50 | 7.9 [1] |
| Oxindole-Based Inhibitor 28 | IC50 | 1.2 [1] |
| Oxindole-Based Inhibitor 30 | IC50 | 93.0 [1] |
| Oxindole-Based Inhibitor 32 | IC50 | 13.0 [1] |
| Oxindole-Based Inhibitor 35 | IC50 | 12.0 [1] |
| Oxindole-Based Inhibitor 36 | IC50 | 19.0 [1] |
| Oxindole-Based Inhibitor 39 | IC50 | 2400.0 [1] |
| Oxindole-Based Inhibitor 41 | IC50 | 34.0 [1] |
| Oxindole-Based Inhibitor 42 | IC50 | 11.0 [1] |
| Oxindole-Based Inhibitor 45 | IC50 | 12.0 [1] |
| Oxindole-Based Inhibitor 46 | IC50 | 15.0 [1] |
| 4-[(5-Amino-2-hydroxy-1H-indol-3-yl)diazenyl]benzenesulfonamide | IC50 | 74.0 [1] |
| Oxindole-Based Inhibitor 64 | IC50 | 43.0 [1] |
| Oxindole-Based Inhibitor 65 | IC50 | 21.0 [1] |
| Oxindole-Based Inhibitor 69 | IC50 | 1000.0 [1], 10000.0 [2] |
| Oxindole-Based Inhibitor 73 | IC50 | 13.0 [1] |
| Oxindole-Based Inhibitor 74 | IC50 | 54.0 [1] |
| Oxindole-Based Inhibitor 75 | IC50 | 4.6 [1] |
| 4-[(5-Chloro-2-hydroxy-7-methyl-1H-indol-3-yl)methylideneamino]benzenesulfonamide | IC50 | 1000.0 [1], 10000.0 [2] |
| 4-[(4-Imidazo[1,2-A]pyridin-3-ylpyrimidin-2-YL)amino]benzenesulfonamide | IC50 | 1.0 [1], 2.0 [2], 3.0 [3] |
| Benzofuranone deriv. 4 | IC50 | 1280.0 [1] |
| Benzofuranone deriv. 5 | IC50 | 3970.0 [1] |
| Benzofuranone deriv. 6 | IC50 | 310.0 [1] |
| Benzofuranone deriv. 7 | IC50 | 30.0 [1] |
| Dasatinib | IC50 | 5000.0 [1] |
| Tofacitinib | IC50 | 10000.0 [1] |
| Palbociclib | IC50 | 10.0 [1], 5000.0 [2] |
| Indazole | IC50 | 185000.0 [1] |
| N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-YL)urea | IC50 | 100000.0 [1] |
| Purvalanol B | IC50 | 6.0 [1], 9.0 [2] |
| Fascaplysin | IC50 | 500000.0 [1] |
| 4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide | IC50 | 47.0 [1] |
| (16E)-14-Methyl-20-oxa-5,7,14,27-tetrazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaene | IC50 | 3.0 [1], 130.0 [2] |
| PDGF Receptor Tyrosine Kinase Inhibitor IV | IC50 | 10000.0 [1] |
| 1-Tert-butyl-3-(naphthalen-1-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 5.0 [1], 29000.0 [2] |
| 1-(Tert-Butyl)-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 15.0 [1], 18000.0 [2] |
| 6-Aryl-pyrazolo[3,4-b]pyridine analogue 13 | IC50 | 5.0 [1] |
| N-[5-Bromo-6-(furan-2-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide | IC50 | 1000.0 [1] |
| Aristolactam AIIIa | IC50 | 140.0 [1] |
| N-(6-Phenyl-1H-indazol-3-yl)cyclopropanecarboxamide | IC50 | 1000.0 [1] |
| Oxindole-Based Inhibitor 81 | IC50 | 1.6 [1] |
| N-[6-(Furan-2-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide | IC50 | 1000.0 [1] |
| N-[6-(3-Sulfamoylphenyl)-1H-indazol-3-yl]cyclopropanecarboxamide | IC50 | 1000.0 [1] |
| N-(2-Chloro-6-methylphenyl)-2-[(2,6-dimethylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide | IC50 | 25000.0 [1] |
| 4-[[5-(Isobutoxycarbonyl)-2-oxoindoline-3-ylidenemethyl]amino]benzenesulfonamide | IC50 | 3.0 [1] |
| Oxindole-Based Inhibitor 33 | IC50 | 21.0 [1] |
| Oxindole-Based Inhibitor 58 | IC50 | 12.0 [1] |
| Oxindole-Based Inhibitor 59 | IC50 | 25.0 [1] |
| Oxindole-Based Inhibitor 62 | IC50 | 6.8 [1] |
| N'-(Pyrrolidino[2,1-B]isoindolin-4-ON-8-YL)-N-(pyridin-2-YL)urea | IC50 | 80.0 [1], 440.0 [2] |